ConductScience.org, home

Paper25754535

Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications.

Liao YJ and 9 others. Int J Cancer, 2015. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications. Papers, record 25754535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25754535

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications.
PubMed
Journal
Int J Cancer
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2022-04-08
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liao YJYi-Jen
2Fang CCCheng-Chieh
3Yen CHChia-Hung
4Hsu SMShih-Ming
5Wang CKChung-Kwe
6Huang SFShiu-Feng
7Liang YCYu-Chih
8Lin YYYing-Yu
9Chu YTYu-Tseng
10Arthur Chen YMYi-Ming

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carrier ProteinsMajor topic
GlycoproteinsMajor topic
Liver NeoplasmsMajor topic
MAP Kinase Signaling SystemMajor topic
Animals
Carcinoma, Hepatocellular
Cell Line
Cell Line, Tumor
Cell Proliferation
Disease Progression
Down-Regulation
Female
HEK293 Cells
Hep G2 Cells
Humans
Mice
Mice, Inbred C57BL
Mice, Inbred NOD
Mice, Knockout
Mice, SCID
Survival Rate
Vesicular Transport Proteins
alpha-Fetoproteins

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42564225A single-cell sequencing-based prognostic model reveals HLA-DRA, NPC2, and PRPF38B as immune-regulatory tumor suppressors in non-small cell lung cancer.Front Cell Dev Biol2026https://conductscience.org/library/papers/42564225PubMed
41816293NPC2 suppresses osteolytic metastasis in lung adenocarcinoma via the AKT/mTOR pathway and tumor-osteoclast crosstalk.iScience2026https://conductscience.org/library/papers/41816293PubMed
41624864Multi-omics integration and machine learning identify NPC2 as a prognostic and treatment-responsive regulator in lung adenocarcinoma.Front Immunol2025https://conductscience.org/library/papers/41624864PubMed
40302802Cholesterol metabolism-related genes predict immune infiltration and prognosis in gastric cancer patients.J Cancer2025https://conductscience.org/library/papers/40302802PubMed
38586328Advances in prognostic models for osteosarcoma risk.Heliyon2024https://conductscience.org/library/papers/38586328PubMed
38402299Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.Sci Rep2024https://conductscience.org/library/papers/38402299PubMed
38216938Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma.Virol J2024https://conductscience.org/library/papers/38216938PubMed
38071335Dysregulated cholesterol regulatory genes in hepatocellular carcinoma.Eur J Med Res2023https://conductscience.org/library/papers/38071335PubMed
38001127Prognostic significance of high NPC2 expression in gastric cancer.Sci Rep2023https://conductscience.org/library/papers/38001127PubMed
37541978Exploring the diagnostic value, prognostic value, and biological functions of NPC gene family members in hepatocellular carcinoma based on a multi-omics analysis.Funct Integr Genomics2023https://conductscience.org/library/papers/37541978PubMed
36819514Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma.Ann Transl Med2023https://conductscience.org/library/papers/36819514PubMed
35053588Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors.Cancers (Basel)2022https://conductscience.org/library/papers/35053588PubMed
34445279Secretory NPC2 Protein-Mediated Free Cholesterol Levels Were Correlated with the Sorafenib Response in Hepatocellular Carcinoma.Int J Mol Sci2021https://conductscience.org/library/papers/34445279PubMed
34138521Hepatocellular carcinoma as a complication of Niemann-Pick disease type C1.Am J Med Genet A2021https://conductscience.org/library/papers/34138521PubMed
33425993Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis.Front Mol Biosci2020https://conductscience.org/library/papers/33425993PubMed
32575795Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects against Sorafenib Resistance in Hepatocellular Carcinoma.Molecules2020https://conductscience.org/library/papers/32575795PubMed
31779269HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma.Cancers (Basel)2019https://conductscience.org/library/papers/31779269PubMed
30923463MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway.Cancer Cell Int2019https://conductscience.org/library/papers/30923463PubMed
29874879Niemann-Pick Type C2 Protein Regulates Free Cholesterol Accumulation and Influences Hepatic Stellate Cell Proliferation and Mitochondrial Respiration Function.Int J Mol Sci2018https://conductscience.org/library/papers/29874879PubMed
29522534Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.PLoS One2018https://conductscience.org/library/papers/29522534PubMed

See all 24 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
MAP2K15604PubTator's text mininghttps://conductscience.org/library/genes/5604NCBI Gene
MAP2K25605PubTator's text mininghttps://conductscience.org/library/genes/5605NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MAPK35595PubTator's text mininghttps://conductscience.org/library/genes/5595NCBI Gene
MIR7-3HG284424PubTator's text mininghttps://conductscience.org/library/genes/284424NCBI Gene
NPC210577PubTator's text mininghttps://conductscience.org/library/genes/10577NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25754535

GET https://conductscience.org/api/papers/v1/25754535/cited_by?page=2